Versant Capital Management’s lululemon athletica LULU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $47.5K | Sell |
416
-620
| -60% | -$82.8K | ﹤0.01% | 1394 |
|
|
2026
Q1 | $159K | Sell |
1,036
-451
| -30% | -$80.8K | 0.02% | 673 |
|
|
2025
Q4 | $309K | Buy |
1,487
+1,102
| +286% | +$200K | 0.04% | 353 |
|
|
2025
Q3 | $68.5K | Sell |
385
-19
| -5% | -$3.81K | 0.01% | 883 |
|
|
2025
Q2 | $96K | Sell |
404
-3
| -0.7% | -$826 | 0.01% | 686 |
|
|
2025
Q1 | $115K | Buy |
407
+224
| +122% | +$82.2K | 0.02% | 585 |
|
|
2024
Q4 | $70K | Buy |
183
+15
| +9% | +$4.9K | 0.02% | 445 |
|
|
2024
Q3 | $45.6K | Buy |
168
+63
| +60% | +$16.7K | 0.01% | 491 |
|
|
2024
Q2 | $31.4K | Buy |
105
+40
| +62% | +$13.4K | 0.01% | 557 |
|
|
2024
Q1 | $25.4K | Hold |
65
| – | – | 0.01% | 433 |
|
|
2023
Q4 | $33.2K | Sell |
65
-5
| -7% | -$2.16K | 0.01% | 358 |
|
|
2023
Q3 | $27K | Buy |
70
+1
| +1% | +$382 | 0.01% | 394 |
|
|
2023
Q2 | $26.1K | Buy |
69
+4
| +6% | +$1.48K | 0.01% | 419 |
|
|
2023
Q1 | $23.7K | Sell |
65
-74
| -53% | -$23.2K | 0.01% | 435 |
|
|
2022
Q4 | $44.5K | Hold |
139
| – | – | 0.02% | 257 |
|
|
2022
Q3 | $39K | Hold |
139
| – | – | 0.02% | 266 |
|
|
2022
Q2 | $38K | Hold |
139
| – | – | 0.01% | 281 |
|
|
2022
Q1 | $51K | Hold |
139
| – | – | 0.02% | 252 |
|
|
2021
Q4 | $54K | Hold |
139
| – | – | 0.02% | 236 |
|
|
2021
Q3 | $56K | Hold |
139
| – | – | 0.02% | 215 |
|
|
2021
Q2 | $51K | Hold |
139
| – | – | 0.02% | 230 |
|
|
2021
Q1 | $43K | Sell |
139
-33
| -19% | -$10.8K | 0.02% | 311 |
|
|
2020
Q4 | $59K | Hold |
172
| – | – | 0.02% | 214 |
|
|
2020
Q3 | $56K | Hold |
172
| – | – | 0.03% | 201 |
|
|
2020
Q2 | $53K | Sell |
172
-3
| -2% | -$767 | 0.02% | 204 |
|
|
2020
Q1 | $33K | Buy |
175
+18
| +11% | +$4.03K | 0.02% | 255 |
|
|
2019
Q4 | $36K | Hold |
157
| – | – | 0.02% | 285 |
|
|
2019
Q3 | $30K | Buy |
157
+4
| +3% | +$748 | 0.01% | 335 |
|
|
2019
Q2 | $27K | Hold |
153
| – | – | 0.01% | 371 |
|
|
2019
Q1 | $25K | Buy |
153
+3
| +2% | +$438 | 0.01% | 508 |
|
|
2018
Q4 | $18K | Hold |
150
| – | – | 0.01% | 578 |
|
|
2018
Q3 | $24K | Hold |
150
| – | – | 0.01% | 550 |
|
|
2018
Q2 | $18K | Hold |
150
| – | – | 0.01% | 669 |
|
|
2018
Q1 | $13K | Hold |
150
| – | – | 0.01% | 800 |
|
|
2017
Q4 | $11K | Hold |
150
| – | – | ﹤0.01% | 884 |
|
|
2017
Q3 | $9K | Hold |
150
| – | – | ﹤0.01% | 892 |
|
|
2017
Q2 | $8K | Hold |
150
| – | – | ﹤0.01% | 930 |
|
|
2017
Q1 | $7K | Sell |
150
-7
| -4% | -$461 | ﹤0.01% | 957 |
|
|
2016
Q4 | $10K | Hold |
157
| – | – | 0.01% | 829 |
|
|
2016
Q3 | $9K | Hold |
157
| – | – | 0.01% | 848 |
|
|
2016
Q2 | $11K | Hold |
157
| – | – | 0.01% | 752 |
|
|
2016
Q1 | $10K | Buy |
157
+7
| +5% | +$420 | 0.01% | 761 |
|
|
2015
Q4 | $7K | Buy |
+150
| New | +$7.56K | ﹤0.01% | 842 |
|
Other funds holding LULU
RT
BRCM
YIH
CNB
TC
SCP
COPPSERS
Versant Capital Management's LULU Position: Q2 2026 in Review
Versant Capital Management reduced its lululemon athletica (LULU) stake by 60% in Q2 2026, selling an estimated $82.8K and leaving 416 shares worth $47.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1394.
Versant Capital Management first reported a position in LULU in Q4 2015 and has held it in 43 quarters since. The position peaked at $309K in Q4 2025. 114 funds tracked by Wall St. Rank hold LULU as of Q2 2026.
- Versant Capital Management held 416 shares of lululemon athletica worth $47.5K as of Q2 2026.
- Versant Capital Management sold 620 lululemon athletica shares in Q2 2026, an estimated $82.8K.
- lululemon athletica made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #1394 holding.
- Versant Capital Management first reported a position in lululemon athletica in Q4 2015 and has held it in 43 quarters since.
- Versant Capital Management's lululemon athletica position peaked at $309K in Q4 2025.
- 114 funds tracked by Wall St. Rank held lululemon athletica as of Q2 2026.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.